These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1171645)

  • 1. Control of estrus with prostaglandin F2alpha in mares: minimal effective dose and stage of estrous cycle.
    Oxender WD; Noden PA; Bolenbaugh DL; Hafs HD
    Am J Vet Res; 1975 Aug; 36(08):1145-7. PubMed ID: 1171645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostaglandin F2alpha on the oestrous cycle and pregnancy in mares.
    Douglas RH; Ginther OJ
    J Reprod Fertil Suppl; 1975 Oct; (23):257-61. PubMed ID: 1060788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrus, ovulation and plasma hormones after prostaglandin F2alpha in mares.
    Oxender WD; Noden PA; Hafs HD
    J Reprod Fertil Suppl; 1975 Oct; (23):251-5. PubMed ID: 1060787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Termination of pseudopregnancy by administration of prostaglandin F2alpha and termination of early pregnancy by administration of prostaglandin F2alpha or colchicine or by removal of embryo in mares.
    Kooistra LH; Ginther OJ
    Am J Vet Res; 1976 Jan; 37(1):35-9. PubMed ID: 1247194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prostaglandin F2alpha-tham salt in mares in clinical anoestrus.
    Kenney RM; Ganjam VK; Cooper WL; Lauderdale JW
    J Reprod Fertil Suppl; 1975 Oct; (23):247-50. PubMed ID: 1060786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of prostaglandin F2alpha in controlling the oestrous cycle of the mare and steroid changes in the peripheral blood.
    Spincemaille J; Coryn M; Vandekerckhove D; Vandeplassche M
    J Reprod Fertil Suppl; 1975 Oct; (23):263-67. PubMed ID: 1060789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrous cycle characteristics, luteal function, secretion of oxytocin (OT) and plasma concentrations of 15-keto-13,14-dihydro-PGF2alpha (PGF2alpha-metabolite) after administration of low doses of prostaglandin F2alpha (PGF2alpha) in pony mares.
    Handler J; Wüstenhagen A; Schams D; Kindahl H; Aurich C
    Theriogenology; 2004 May; 61(7-8):1573-82. PubMed ID: 15036986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiluteogenic effects of serial prostaglandin F2α administration in cycling mares.
    Coffman EA; Pinto CR; Snyder HK; Leisinger CA; Cole K; Whisnant CS
    Theriogenology; 2014 Dec; 82(9):1241-5. PubMed ID: 25234788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare.
    Glazar BS; McCue PM; Bruemmer JE; Squires EL
    Theriogenology; 2004 Jul; 62(1-2):57-64. PubMed ID: 15159101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation synchrony after follicle ablation in mares.
    Bergfelt DR; Adams GP
    J Reprod Fertil Suppl; 2000; (56):257-69. PubMed ID: 20681137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated daily injections of prostaglandin F2alpha on ovaries in mares.
    Douglas RH; Ginther OJ
    Prostaglandins; 1976 Nov; 12(5):881-94. PubMed ID: 988608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrus, ovulation, and serum hormones in mares given prostaglandin F2 alpha, estradiol, and gonadotropin-releasing hormone.
    Booth LC; Oxender WD; Douglas RH; Woodley SL
    Am J Vet Res; 1980 Jan; 41(1):120-2. PubMed ID: 6987921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral serum progesterone and luteinizing hormone concentrations of goats during synchronization of estrus and ovulation with prostaglandin F2 alpha.
    Ott RS; Nelson DR; Hixon JE
    Am J Vet Res; 1980 Sep; 41(9):1432-4. PubMed ID: 7192524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolysis following carotid or ovarian arterial injection of prostaglandin F2alpha in mares.
    Douglas RH; Del Campo MR; Ginther OJ
    Biol Reprod; 1976 May; 14(4):473-7. PubMed ID: 945080
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum luteinizing hormone, estrus, and ovulation in mares following treatment with prostaglandin F2alpha and gonadotropin-releasing hormone.
    Oxender WD; Noden PA; Pratt MC
    Am J Vet Res; 1977 May; 38(5):649-53. PubMed ID: 327873
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of prostaglandins for synchronization of oestrus and treatment of prolonged dioestrus in mares.
    Allen WR
    Acta Vet Scand Suppl; 1981; 77():227-39. PubMed ID: 7030026
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of the interval from PGF treatment to ovulation on embryo recovery and pregnancy rate in the mare.
    Cuervo-Arango J; Mateu-Sánchez S; Aguilar JJ; Nielsen JM; Etcharren V; Vettorazzi ML; Newcombe JR
    Theriogenology; 2015 May; 83(8):1272-8. PubMed ID: 25666044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged interovulatory interval after oestradiol treatment in mares.
    Woodley SL; Burns PJ; Douglas RH; Oxender WD
    J Reprod Fertil Suppl; 1979; (27):205-9. PubMed ID: 289791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of PGF2alpha and 13,14-dihydro-15-keto-PGF2alpha (PGFM) on corpora luteal function in nonpregnant mares.
    Vanderwall DK; Betschart RW; Squires EL
    Theriogenology; 2000 Apr; 53(6):1263-71. PubMed ID: 10832751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the ability of altrenogest to control the equine estrous cycle.
    Lofstedt RM; Patel JH
    J Am Vet Med Assoc; 1989 Feb; 194(3):361-4. PubMed ID: 2645256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.